Treatment of gastroesophageal reflux disease
US7358245B2 · kind B2 · utility
1Cited by
1References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 20, 2002 |
| Grant date | Apr 15, 2008 |
| Priority date | — |
| Expiry date | Aug 19, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The administration of cannabinoid receptor agonists for inhibition of transient lower esophageal sphincter relaxations, gastroesophageal reflux disease and regurgitation is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.